These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 36028084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?
    Bohley M, Leroux JC.
    Adv Sci (Weinh); 2024 Sep; 11(33):e2400843. PubMed ID: 38884149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
    Kneiszl R, Hossain S, Larsson P.
    Mol Pharm; 2022 Jan 03; 19(1):124-137. PubMed ID: 34913341
    [Abstract] [Full Text] [Related]

  • 7. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
    Hossain S, Joyce P, Parrow A, Jõemetsa S, Höök F, Larsson P, Bergström CAS.
    Mol Pharm; 2020 Nov 02; 17(11):4226-4240. PubMed ID: 32960068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
    Hossain S, Kneiszl R, Larsson P.
    Nanoscale; 2023 Dec 07; 15(47):19180-19195. PubMed ID: 37982184
    [Abstract] [Full Text] [Related]

  • 12. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
    Kim JC, Park EJ, Na DH.
    Pharmaceuticals (Basel); 2022 Dec 19; 15(12):. PubMed ID: 36559036
    [Abstract] [Full Text] [Related]

  • 13. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
    Dening TJ, Douglas JT, Hageman MJ.
    Mol Pharm; 2021 Aug 02; 18(8):3086-3098. PubMed ID: 34255531
    [Abstract] [Full Text] [Related]

  • 14. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
    Mortensen JS, Bohr SS, Harloff-Helleberg S, Hatzakis NS, Saaby L, Nielsen HM.
    J Control Release; 2022 Dec 02; 352():163-178. PubMed ID: 36314534
    [Abstract] [Full Text] [Related]

  • 15. Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.
    Berg S, Kärrberg L, Suljovic D, Seeliger F, Söderberg M, Perez-Alcazar M, Van Zuydam N, Abrahamsson B, Hugerth AM, Davies N, Bergström CAS.
    Mol Pharm; 2022 Jan 03; 19(1):200-212. PubMed ID: 34928160
    [Abstract] [Full Text] [Related]

  • 16. Safety concerns over the use of intestinal permeation enhancers: A mini-review.
    McCartney F, Gleeson JP, Brayden DJ.
    Tissue Barriers; 2016 Jan 03; 4(2):e1176822. PubMed ID: 27358756
    [Abstract] [Full Text] [Related]

  • 17. SNAC for Enhanced Oral Bioavailability: An Updated Review.
    Kommineni N, Sainaga Jyothi VGS, Butreddy A, Raju S, Shapira T, Khan W, Angsantikul P, Domb AJ.
    Pharm Res; 2023 Mar 03; 40(3):633-650. PubMed ID: 36539668
    [Abstract] [Full Text] [Related]

  • 18. Identification of a Multi-Component Formulation for Intestinal Delivery of a GLP-1/Glucagon Co-agonist Peptide.
    Tran H, Patel PJ, Aburub A, Sperry A, Estwick S, ElSayed MEH, -Mannan AD.
    Pharm Res; 2022 Oct 03; 39(10):2555-2567. PubMed ID: 36050547
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.